SAFER@WORK
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SAFER@WORK Trademark

Serial Number: 79318434 • Registration: 6674702

SAFER@WORK is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED on December 14, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED (43 trademarks)

Entity Type: 99

Trademark Details

Filing Date

December 14, 2020

Registration Date

March 22, 2022

Published for Opposition

January 4, 2022

Goods & Services

Medical chemical test reagents; veterinary chemical test reagents; testing kits for medical use comprised of medical diagnostic reagents and assays for testing body fluids

Medical testing services, namely, blood testing, saliva, urine, tissue, hair and body fluid testing services for diagnostic or treatment purposes; serological and urinary testing services for medical, epidemiological and veterinary purposes; medical testing services in the field of epidemiology and genetics; DNA and RNA analyses for medical testing purposes; DNA and RNA screening for medical purposes; viral screening for medical purposes; medical and health assessment services in connection with DNA and RNA; genetic testing for medical purposes; hospital services; medical assistance services and medical services in the field of epidemiology and genetics; medical clinic services; medical consultation services; medical consultation in the fields of genetics and epidemiology; provision of online medical information in the nature of maintaining patient medical records online; collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids for medical purposes; medical testing for diagnostic and epidemiological treatment purposes; medical testing for diagnostic or treatment epidemiological purposes; medical testing for diagnostic purposes in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of test panels in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of medical biology test panels and the interpretation of medical biology test results; bio-pathological medical information and advice relating to medical biology tests; medical testing for diagnostic and treatment purposes featuring testing for assessing immunogenicity, hypersensitivity and adverse immune stimulation; medical testing for diagnostic or treatment purposes in the field of infectious diseases; prenatal diagnostic testing for medical purposes; consultancy of medical treatment in the nature of medical analysis for the diagnosis and treatment of persons

Scientific research; industrial research in the field of animal and plant biology, physical chemistry, food chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry and environmental testing; scientific research and development in the fields of animal and plant biology, physical chemistry, food chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses, clinical and in-vitro studies in the food and feed, agro, chemical, pharmaceutical, cosmetic, personal care, environmental, agrochemical, biotechnology, aero-space, automobile, consumer products, semiconductor, electronics, energy, magnetic storage and any science-oriented industries and in environmental testing; carrying out scientific study and research in the fields of genetic analyses in the fields of plant and animal products; carrying out scientific study and research in the fields of genetic analyses in the food, feed, agro, chemical, pharmaceutical, cosmetic, personal care, biotechnology and consumer products industries and in environmental testing; development of methods, namely, establishment and carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; preparation of scientific reports in the field of scientific, medical and industrial research for scientists and engineers; technical research in the field of pharmaceutical project studies; professional consultancy in the field of scientific and medical research; planning and developing services for gene libraries for scientific, medical and veterinary use, namely, collecting DNA and RNA fragments, variants or combination of genes for medical or veterinary use; scientific and technological services, namely, scientific research, scientific analysis, inspection of environmental surfaces, work places and public places, audit in the nature of environmental inspection, scientific research consulting, industrial design, engineering, scientific development and genetic laboratory testing services for research purposes for others in the field of genetics and epidemiology; taking and analysis of biological samples for third parties for environmental, agricultural, food, feed and genetic testing; consultancy and advisory services relating to quality testing services in the environmental, agricultural and food industry; database design and development; providing online information about industrial analysis and research services; information technology (IT) services, namely, programming online searchable databases and algorithms for managing and providing scientific analysis results based on genomics data; providing online information in the field of technological research relating to environmental testing, genetics and epidemiology from a computer database or the Internet; pharmaceutical drug discovery services; new product development and research in the fields of pharmaceuticals, biotech products, chemicals and agrochemicals; conducting clinical trials for pharmaceutical drugs for others; scientific research services in the areas of genomics, proteomics, chemistry, pharmacology, biology, epidemiology medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; providing scientific information in the fields of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data by using information technology tools and techniques; conducting clinical trials for others in the fields of pharmaceuticals, products, cosmetics and personal care products; safety and efficiency testing and evaluation services, namely, quality evaluation and analysis, quality assurance, for pharmaceutical drugs; conducting research and studies using information technology tools and techniques in the field of epidemiology, genomics and proteomics of living organs including human beings, included in this class; scientific and technological services, namely, scientific and medical laboratory services, laboratory research and development in the fields of epidemiology, biomedicine and biobanking; quality audits relating to the hygiene of hospitals, food industry, restaurants, hotels and retailers' sites or any public places in the nature of bacteriological testing; technical scientific and scientific observation, monitoring and analysis in the consumer product industry, the food industry, the hospitality industry and for retail premises and consultancy relating thereto; product quality inspection for consumer products, food and feed industry and healthcare industry for quality control purposes; quality audits and certification of systems against national and international standards in the consumer product industry, food and feed industry, hospitality industry and healthcare industry to determine whether systems and processes conform to health and safety standards against which the systems are assessed; consultation and analysis services for scientific purposes in the fields of biotechnology, pharmaceutical research and development, diagnostic testing and drug therapy research; personal protective equipment testing; inspection services, namely, inspection of premises for quality control purposes; work place inspection services, namely, inspection of work places for purposes of repair and restoration; bacteriological surface testing; surface testing, namely, testing for the absence of bacteria and virus; testing of viral clearance in products and on surfaces; DNA and RNA analyses for scientific research purposes; DNA and RNA screening for scientific research purposes; viral screening for scientific research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 19, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 18, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 22, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 22, 2022 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Feb 3, 2022 CHPB
ASSIGNED TO PETITION STAFF
Feb 1, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 21, 2022 EPPA
NOTIFICATION PROCESSED BY IB
Jan 10, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 4, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 4, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 22, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 22, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2021 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 2, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2021 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2021 TROA
ATTORNEY REVIEW COMPLETED
Oct 8, 2021 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Oct 8, 2021 CREV
REFUSAL PROCESSED BY IB
Oct 4, 2021 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 19, 2021 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 9, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 9, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 29, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 28, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 27, 2021 MAFR
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 19, 2021 REPR